Summary
This prediction ended on 05.11.21 with a price of €39.30. With a performance of 71.02% the BUY prediction by Lutz69 was a big success. Lutz69 has 50% into this predictionEvotec is a German-based biotech company that provides drug discovery and development solutions to pharmaceutical and biotechnology companies. The company operates in the fields of neuroscience, immunology, oncology, and infectious diseases, and its services include hit identification, target validation, and preclinical and clinical development. Evotec has partnerships with major pharmaceutical companies and has developed its own pipeline of drugs, with a focus on developing treatments for conditions such as Alzheimer's disease and diabetes. The company is listed on the Frankfurt and NASDAQ stock exchanges and has a market capitalization of approximately €5.5 billion.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Evotec SE | -30.593% | -30.593% | -44.574% | -72.395% |
| iShares Core DAX® | 1.051% | -1.833% | 12.822% | 15.392% |
| iShares Nasdaq 100 | -0.547% | -3.738% | 40.625% | 42.396% |
| iShares Nikkei 225® | -1.778% | -8.115% | 16.092% | 0.891% |
| iShares S&P 500 | 0.002% | -2.226% | 28.387% | 41.095% |
According to Lutz69 what are the pros and cons of Evotec SE for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by Lutz69 for this prediction
In the thread Evotec AG diskutieren
Kursziel geändert auf 29,0
In the thread Trading Evotec AG
Die von Lutz69 gewählte maximale Laufzeit wurde überschritten